Inventor

ZABLOCKI JEFF

US134 patents

⚠️ This page may combine multiple inventors who share the name “ZABLOCKI JEFF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZABLOCKI JEFF

GILEAD SCIENCES INC

Toll like receptor modulator compounds

Toll like receptor modulator compounds

Toll like receptor modulator compounds

Fused heterocyclic compounds as ion channel modulators

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Inhibitors of hepatitis C virus

Compounds for the treatment of addiction

Toll like receptor modulator compounds

Toll like receptor modulator compounds

Toll like receptor modulator compounds

Fused heterocyclic compounds as ion channel modulators

Compounds for the treatment of addiction

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Compounds for the treatment of addiction

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Substituted 6-azabenzimidazole compounds

Benzimidazole derivatives as bromodomain inhibitors

Substituted pyrrolidines as SYK inhibitors

CV THERAPEUTICS INC

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

N-pyrazole A2A receptor agonists

Heteroaryl alkyl piperazine derivatives

Aralkyl substituted piperazine compounds

Substituted piperazine compounds

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

Partial and full agonists of A1 adenosine receptors

Substituted alkyl piperazine derivatives

ABCA-1 elevating compounds

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

Partial and full agonists A1 adenosine receptors

Substituted piperazine compounds

GILEAD PALO ALTO INC

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

A2B adenosine receptor antagonists

Prodrugs of A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

CORKEY BRITTON

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Apoptosis signal-regulating kinase inhibitors

ZABLOCKI JEFF

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

CORKEY BRITTON KENNETH

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

KOBAYASHI TETSUYA

Fused heterocyclic compounds as ion channel modulators